Re188 lipiodol therapy in liver cancer with portal vein thrombosis: a promising alternative

Conclusions: Re-188 lipiodol trans-arterial radionuclide therapy appears to be a promising alternative treatment in HCC with PVT. However, more work in this area maybe required for streamlining dosimetry and patient selection in order to improve outcome.

Source: Journal of Nuclear Medicine - May 20, 2019 Category: Nuclear Medicine Authors: Datta Gupta, S., Shamim, S., Gamanagatti, S., ., S., Gupta, P., Khan, M., Singh, P., Hussain, J., Mallia, M., Chirayil, V., Dash, A., Bal, C. Tags: Other Solid Tumors/ Hematologic Malignancies (Clinical) I Source Type: research